Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterization of TRPC6 to Predict and Prevent Chemotherapy Related Cardiomyopathy and Heart Failure (Prospective Study)

NCT05507879 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT05507879
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05507879 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterization of TRPC6 to Predict and Prevent Chemotherapy Related Cardiomyopathy and Heart Failure (Prospective Study)
Lead sponsor
Mayo Clinic
Phase
Observational
Overall status
Recruiting
Start date
September 26, 2022
Completion date
July 1, 2030
Enrollment
200 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast carcinoma, cardiomyopathy, congestive heart failure